Combe Inc. v. Dr. Aug. Wolff GMBH & Co.

283 F. Supp. 3d 519
CourtDistrict Court, E.D. Virginia
DecidedDecember 19, 2017
DocketCase No. 1:17–cv–935
StatusPublished
Cited by4 cases

This text of 283 F. Supp. 3d 519 (Combe Inc. v. Dr. Aug. Wolff GMBH & Co.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Combe Inc. v. Dr. Aug. Wolff GMBH & Co., 283 F. Supp. 3d 519 (E.D. Va. 2017).

Opinion

T.S. Ellis, III, United States District Judge

At issue in this appeal from a decision by the U.S. Trademark Trial and Appeal Board ("TTAB") pursuant to 15 U.S.C. § 1071(b)(1) is whether personal jurisdiction exists over the defendant with respect to trademark infringement and unfair competition claims separate from the TTAB decision at issue on this appeal.

I.1

Plaintiff, Combe Incorporated, is a Delaware corporation and a leading maker of personal-care products for men and women. In particular, since approximately 1973, plaintiff has offered and sold a wide variety of women's personal care products, including medicated creams, moisturizers, deodorant powders, wipes, gels, washes and other products, under the trademark VAGISIL. Defendant, Dr. August Wolff GmbH & Co. KG Arzneimmitel, is a German limited liability partnership that manufactures medicinal, cosmetic and dermatological products, including feminine products under the label VAGISAN. Defendant maintains its headquarters in Bielefeld, Germany and has no offices or employees in the United States. Defendant's products are authorized for sale primarily in Belgium, Bulgaria, Estonia, Finland, Germany, Iraq, Iran, Jordan, Croatia, Lithuania, Latvia, Austria, Poland, Portugal, Switzerland, Serbia/Montenegro, Slovenia, Czech Republic, Turkey, Hungary, and the United Kingdom. At this time, defendant has not yet sold any products in the United States, but defendant has taken steps toward entering the U.S. market, including: filing an application with the U.S. Food & Drug Administration ("FDA") for approval of the VAGISAN moisturizing cream and entering into discussions with distributors, consultants, and independent contractors regarding the development of a program to sell VAGISAN products in the United States.

Defendant also filed an application with the U.S. Patent & Trademark Office ("PTO") to register the mark VAGISAN for "pharmaceutical preparations, namely, *521vaginal moisturizers, vaginal anti-fungal preparations, vaginal washes; sanitary preparations for medical use; diet pills, diet capsules, diet liquid medications" and "soaps, perfumery, essential oils, cosmetics, hair lotions." Compl. ¶ 26. Plaintiff opposed this trademark application, arguing that defendant's use of a VAGISAN mark would create a likelihood of confusion with plaintiff's existing registered VAGSIL mark. Following consideration of evidence submitted by the parties on the likelihood of confusion, the TTAB issued a final decision on June 19, 2017, dismissing plaintiff's opposition and determining that the VAGISAN mark did not so resemble the VAGISIL mark as to be likely to cause "confusion," "mistake," or "deception" pursuant to 15 U.S.C. § 1052. See Combe Inc. v. Dr. August Wolff GmbH & Co. KG Arzneimittel , Opposition No. 91209708, 2017 WL 3034058 (TTAB June 19, 2017).

Thereafter, plaintiff filed this action on August 21, 2017 pursuant to 15 U.S.C. § 1071(b)(4), which allows a party otherwise entitled to appeal a TTAB decision to institute a suit against the party in interest in the Eastern District of Virginia. In addition to its appeal of the final TTAB decision on registration of the VAGISAN mark, plaintiff brings five federal and state claims against defendant, including:

(i) a claim for trademark infringement under the Lanham Act;
(ii) a claim for trademark infringement, false designation of origin, passing off, and unfair competition under the Lanham Act;
(iii) a claim for trademark dilution under the Lanham Act;
(iv) a claim for trademark infringement under the Virginia Trademark and Service Mark Act; and
(v) a claim for trademark infringement and unfair competition under Virginia Common Law.

On November 6, 2017, defendant filed a motion to dismiss each of these claims, apart from the claim stemming from the § 1071 TTAB appeal, for lack of personal jurisdiction pursuant to Rule 12(b)(2), Fed. R. Civ. P. In support of this motion, defendant argues that because defendant has never sold products in the United States and maintains no offices in the United States, defendant does not possess the requisite minimum contacts with either Virginia or the United States to support personal jurisdiction. Plaintiff opposes the motion, arguing that defendant is subject to personal jurisdiction pursuant both to 15 U.S.C. § 1071(b)(1) and to Rule 4(k)(2), Fed. R. Civ. P. These issues have been fully briefed and argued and are now ripe for disposition.

II.

It is well-settled that the Due Process Clause of the U.S. Constitution requires a nonresident defendant to have "certain minimum contacts with [the forum state] such that the maintenance of the suit does not offend traditional notions of fair play and substantial justice." Int'l Shoe Co. v. Wash. , 326 U.S. 310, 316, 66 S.Ct. 154, 90 L.Ed. 95 (1945) (quotation marks omitted). It is equally well-settled that resolution of personal jurisdiction challenges generally requires courts to consider (i) whether the state long-arm statute reaches the non-resident defendant given the cause of action alleged and the nature of the defendant's contacts; and (ii) whether the long-arm statute's reach in the circumstances exceeds its constitutional grasp. See Ellicott Mach. Corp., Inc. v. John Holland Party Ltd. , 995 F.2d 474, 477 (4th Cir. 1993). Were these principles the only principles governing defendant's motion to dismiss here, defendant might well have a persuasive motion. But importantly, another principle governs here-the doctrine of pendent personal jurisdiction *522as adopted by the Fourth Circuit.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
283 F. Supp. 3d 519, Counsel Stack Legal Research, https://law.counselstack.com/opinion/combe-inc-v-dr-aug-wolff-gmbh-co-vaed-2017.